These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17542669)

  • 1. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody.
    Sanders J; Chirgadze DY; Sanders P; Baker S; Sullivan A; Bhardwaja A; Bolton J; Reeve M; Nakatake N; Evans M; Richards T; Powell M; Miguel RN; Blundell TL; Furmaniak J; Smith BR
    Thyroid; 2007 May; 17(5):395-410. PubMed ID: 17542669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.
    Sanders P; Young S; Sanders J; Kabelis K; Baker S; Sullivan A; Evans M; Clark J; Wilmot J; Hu X; Roberts E; Powell M; Núñez Miguel R; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2011 Apr; 46(2):81-99. PubMed ID: 21247981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular interactions between the TSH receptor and a Thyroid-stimulating monoclonal autoantibody.
    Sanders J; Miguel RN; Bolton J; Bhardwaja A; Sanders P; Nakatake N; Evans M; Furmaniak J; Smith BR
    Thyroid; 2007 Aug; 17(8):699-706. PubMed ID: 17725428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.
    Núñez Miguel R; Sanders J; Chirgadze DY; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2009 May; 42(5):381-95. PubMed ID: 19221175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a thyroid-stimulating human monoclonal autoantibody (M22) on functional activity of LH and FSH receptors.
    Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; Pinchera A; Sanders J; Evans M; Richards T; Furmaniak J; Smith BR
    Thyroid; 2006 Nov; 16(11):1085-9. PubMed ID: 17123334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.
    Hamidi S; Chen CR; McLachlan SM; Rapoport B
    Thyroid; 2011 Sep; 21(9):1013-20. PubMed ID: 21834684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FSH and TSH binding to their respective receptors: similarities, differences and implication for glycoprotein hormone specificity.
    Núñez Miguel R; Sanders J; Chirgadze DY; Blundell TL; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2008 Sep; 41(3):145-64. PubMed ID: 18606720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.
    Sanders J; Jeffreys J; Depraetere H; Evans M; Richards T; Kiddie A; Brereton K; Premawardhana LD; Chirgadze DY; Núñez Miguel R; Blundell TL; Furmaniak J; Rees Smith B
    Thyroid; 2004 Aug; 14(8):560-70. PubMed ID: 15320966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.
    Núñez Miguel R; Sanders J; Sanders P; Young S; Clark J; Kabelis K; Wilmot J; Evans M; Roberts E; Hu X; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2012 Oct; 49(2):137-51. PubMed ID: 22829655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
    Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
    Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a ligand-free stable TSH receptor leucine-rich repeat domain.
    Miller-Gallacher J; Sanders P; Young S; Sullivan A; Baker S; Reddington SC; Clue M; Kabelis K; Clark J; Wilmot J; Thomas D; Chlebowska M; Cole F; Pearson E; Roberts E; Holly M; Evans M; Núñez Miguel R; Powell M; Sanders J; Furmaniak J; Rees Smith B
    J Mol Endocrinol; 2019 Apr; 62(3):117-128. PubMed ID: 30689545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
    Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
    Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH receptor antibodies.
    Smith BR; Sanders J; Furmaniak J
    Thyroid; 2007 Oct; 17(10):923-38. PubMed ID: 17900238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.
    Sanders J; Bolton J; Sanders P; Jeffreys J; Nakatake N; Richards T; Evans M; Kiddie A; Summerhayes S; Roberts E; Miguel RN; Furmaniak J; Smith BR
    Thyroid; 2006 Dec; 16(12):1195-206. PubMed ID: 17199429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.
    Sanders J; Miguel RN; Furmaniak J; Smith BR
    Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema.
    Kamath C; Young S; Kabelis K; Sanders J; Adlan MA; Furmaniak J; Rees Smith B; Premawardhana LD
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):465-70. PubMed ID: 22891608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of a TSH receptor monoclonal antibody: insight into Graves' disease pathogenesis.
    Chen CR; Hubbard PA; Salazar LM; McLachlan SM; Murali R; Rapoport B
    Mol Endocrinol; 2015 Jan; 29(1):99-107. PubMed ID: 25419797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone- and antibody-mediated activation of the thyrotropin receptor.
    Duan J; Xu P; Luan X; Ji Y; He X; Song N; Yuan Q; Jin Y; Cheng X; Jiang H; Zheng J; Zhang S; Jiang Y; Xu HE
    Nature; 2022 Sep; 609(7928):854-859. PubMed ID: 35940204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing structural variability at the N terminus of the TSH receptor with a murine monoclonal antibody that distinguishes between two receptor conformational forms.
    Hamidi S; Chen CR; Murali R; McLachlan SM; Rapoport B
    Endocrinology; 2013 Jan; 154(1):562-71. PubMed ID: 23183178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.